Eli Lilly (LLY)
$115.36 0.27 (0.23%)
18:27 EDT LLY Stock Quote Delayed 15 Minutes
Previous Close $115.36
Market Cap 125.22B
PE Ratio 107.81
Volume (Avg. Vol.) 2.11M
Day's Range 115.17 - 116.83
52-Week Range 84.64 - 132.13
Dividend & Yield 2.25 (1.95%)
LLY Stock Predictions, Articles, and Eli Lilly News
- From InvestorPlace
- From the Web
The stock charts of HRL, JNPR and LLY stock are moving into the midpoint of the week on the cusp of something trade-worthy.
Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.
AZN stock is great to own, but you should choose your entry points carefully, as AstraZeneca has some short-term risks ahead.
The bull thesis in Eli Lilly stock has strong qualitative and quantitative support, making it pretty hard to refute or ignore.
A recent article in the investment media asked if Pfizer stock was a better buy than Eli Lilly stock. Here’s why I wouldn’t buy either.
In 2018, Humalog generated $3.0 billion for Eli Lilly, 5% higher than a year earlier. Assuming Humalog’s gross margin is 73.8% (I’m using the company’s overall gross margin; it’s likely higher), Eli Lilly had $2.2 billion in gross profits from this single drug. Except for Trulicity, the company’s bestselling diabetes drug, Humalog is the company’s second-largest revenue and profit generator.
The stock charts of PPL, CF and DHI are all on the precipice of major moves, though each one has one more hurdle to clear.
The stock charts of LLY, LKQ and CNC deserve a closer look through a technical trading lens as the trading week winds down.
Options trading was abuzz in Eli Lilly, Twitter and Freeport-McMoRan on Wednesday. Here are the metrics and levels that matter here.
In the latest Eli Lilly news, LLY stock fell more than 2% as the company's late-stage trial of a sarcoma study failed to meet its goals.
Pharmaceutical stocks have been on the rebound and many are raising their prices this year. What does that mean for business?
Roku soared, while the S&P 500, Twilio, Eli Lilly and Nvidia all perked up as well. Here are a few must-see stock charts for Tuesday.
Loxo Oncology (LOXO) stock was flying high on Monday following news of an $8-billion deal between it and Eli Lilly (LLY).
LLY stock is worth a look after Eli Lilly claims its new drugs may provide 45% of 2019 revenue and it can afford to raise its dividend 15%.
These seven stocks are resisting widespread market volatility and will help investors with surviving a bear market. Here's what you need to know about each.
The healthcare sector remains firm even as bears ravage the market. Here are three healthcare stocks to consider during the downturn.
Trump and House Democrats look poised to make deals that will hurt these stocks to sell. Here's what investors need to know.
Earnings set to the tone for Toyota, CVS Health, Eli Lilly and Mylan as our top stock trades. But midterms will set the tone for the week.
From Seeking Alpha
From Seeking Alpha
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!